Follow the Pundits
Tag: hedge funds
🎩 Pershing Square USA (PSUS): IPO Drop, Insider Skill & the Ackman Question
Bill Ackman’s Pershing Square USA (PSUS) IPO promised Berkshire-style investing for the digital age—but the market responded with an 18% drop on day one. Is this a rare opportunity to buy elite hedge fund skill at a discount, or a structural trap hiding behind influence?
🐎 David Tepper’s Appaloosa Portfolio 2026: The 153% Return Playbook
David Tepper’s Appaloosa LP has delivered a staggering 153% return over three years. Here’s a breakdown of his top holdings, bold strategy shifts, and what investors can learn.
🏔️ John Paulson 2025: From "Short of the Century" to the "Long of the Decade"
John Paulson is back. After years under the radar, the legendary investor posted a 58% return in 2025—driven by high-conviction bets in biotech, gold, and strategic minerals. This is not diversification. This is precision investing.
Baillie Gifford Review 2026: The Long-Term Kings of Disruptive Growth 🏴☠️
Baillie Gifford invests like a time traveler—betting on companies that could dominate the next decade. But with great upside comes serious volatility. Here’s the full 2026 breakdown.
Ackman IPO: Genius Play or Structural Trap? 🎩📉
Bill Ackman is opening the gates to his investing empire—but is this IPO a golden ticket or a cleverly packaged trade-off? From NAV discounts to DIY replication, here’s the real audit behind the hype.
🏰 The $387 Billion Macro-Machine: Inside Fisher Investments (2026 Edition)
Fisher Investments doesn’t start with stocks—it starts with the world. With $387B under management, this macro-first powerhouse takes a very different approach to investing. Here’s what’s really going on under the hood.
Sweetgreen (SG): 90% Down—Turnaround or Trap? 🥗📉
Sweetgreen looks fresh on the menu—but the stock tells a different story. With high short interest, insider buying, and weak fundamentals, SG is a high-risk contrarian bet investors should approach carefully.
John Paulson’s $5,000 Gold Bet: Genius or Gamble? 🚀
A hyper-concentrated portfolio, a $5,000 gold target, and massive biotech bets—John Paulson is back with one of the boldest strategies in markets today.
🚀 Ken Fisher’s 2025 Performance Review: The $300B AI & Tech "Flex"
Ken Fisher didn’t chase alpha in 2025—he owned the market’s center of gravity. A $300B portfolio, 1,000+ stocks, and one clear message: sometimes the obvious winners win.
Coatue’s AI Master Plan: Chips, Power, and the New Token Economy
Coatue has evolved from a tech hedge fund into an AI city planner—buying chips, power, and infrastructure while others chase apps. A deep dive into Philippe Laffont’s blueprint for the token economy.